EA200300750A1 - Применение антигестагенов для ингибирования ускоренного созревания эндометрия в процессе лечения бесплодия - Google Patents

Применение антигестагенов для ингибирования ускоренного созревания эндометрия в процессе лечения бесплодия

Info

Publication number
EA200300750A1
EA200300750A1 EA200300750A EA200300750A EA200300750A1 EA 200300750 A1 EA200300750 A1 EA 200300750A1 EA 200300750 A EA200300750 A EA 200300750A EA 200300750 A EA200300750 A EA 200300750A EA 200300750 A1 EA200300750 A1 EA 200300750A1
Authority
EA
Eurasian Patent Office
Prior art keywords
maturation
treatment
antigestagenes
endometry
infertility
Prior art date
Application number
EA200300750A
Other languages
English (en)
Other versions
EA008057B1 (ru
Inventor
Криста Хегеле-Хартунг
Хольгер Хесс-Штумпп
Хеннинг М. Байер
Клаудиа Круше
Original Assignee
Шеринг Акциенгезельшафт
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Шеринг Акциенгезельшафт filed Critical Шеринг Акциенгезельшафт
Priority claimed from PCT/IB2002/001764 external-priority patent/WO2002067910A2/en
Publication of EA200300750A1 publication Critical patent/EA200300750A1/ru
Publication of EA008057B1 publication Critical patent/EA008057B1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

В заявке описан способ ингибирования ускоренного созревания эндометрия у самки млекопитающего, подвергающейся лечению с целью повышения фертильности. Способ заключается в том, что самке млекопитающего вводят по меньшей мере один 17α-фторалкилированный антагонист рецептора прогестерона.Отчет о международном поиске был опубликован 2003.02.06.
EA200300750A 2001-01-09 2002-01-09 Способы ингибирования ускоренного созревания эндометрия у женщины и самки млекопитающего кроме человека и способы достижения состояния беременности у женщины и самки млекопитающего кроме человека EA008057B1 (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US75628601A 2001-01-09 2001-01-09
US09/801,925 US20020143000A1 (en) 2001-01-09 2001-03-09 Use of antigestagens for inhibiting accelerated endometrial maturation during infertility treatment
PCT/IB2002/001764 WO2002067910A2 (en) 2001-01-09 2002-01-09 The use of antigestagens for inhibiting accelerated endometrial maturation during infertility treatment

Publications (2)

Publication Number Publication Date
EA200300750A1 true EA200300750A1 (ru) 2003-12-25
EA008057B1 EA008057B1 (ru) 2007-02-27

Family

ID=25042810

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200300750A EA008057B1 (ru) 2001-01-09 2002-01-09 Способы ингибирования ускоренного созревания эндометрия у женщины и самки млекопитающего кроме человека и способы достижения состояния беременности у женщины и самки млекопитающего кроме человека

Country Status (8)

Country Link
US (1) US20020143000A1 (ru)
KR (1) KR20030070096A (ru)
EA (1) EA008057B1 (ru)
PE (1) PE20020804A1 (ru)
PT (1) PT1365765E (ru)
UA (1) UA80529C2 (ru)
YU (1) YU55403A (ru)
ZA (1) ZA200306122B (ru)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102006054535A1 (de) * 2006-11-15 2008-05-21 Bayer Schering Pharma Aktiengesellschaft Progesteronrezeptorantagonisten
DE102009034366A1 (de) 2009-07-20 2011-01-27 Bayer Schering Pharma Aktiengesellschaft 17-Hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-methylenoxyalkylenaryl-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung zur Behandlung von Krankheiten
DE102009034362A1 (de) * 2009-07-20 2011-01-27 Bayer Schering Pharma Aktiengesellschaft 17-Hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-aryl-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung zur Behandlung von Krankheiten
DE102009034367A1 (de) 2009-07-20 2011-01-27 Bayer Schering Pharma Aktiengesellschaft 17-Hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-benzyliden-Derivate, Verfahren zu deren Herstellung und deren Verwendung zur Behandlung von Krankheiten
DE102009034368A1 (de) 2009-07-20 2011-01-27 Bayer Schering Pharma Aktiengesellschaft 17-Hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-acyloxyalkylenphenyl-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung zur Behandlung von Krankheiten
DE102009034526A1 (de) 2009-07-21 2011-02-10 Bayer Schering Pharma Aktiengesellschaft 17-Hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-ethinylphenyl-Derivate, Verfahren zu deren Herstellung und deren Verwendung zur Behandlung von Krankheiten
DE102009034525A1 (de) 2009-07-21 2011-01-27 Bayer Schering Pharma Aktiengesellschaft 17-Hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-aryl-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung zur Behandlung von Krankheiten
DE102010007722A1 (de) 2010-02-10 2011-08-11 Bayer Schering Pharma Aktiengesellschaft, 13353 Progesteronrezeptorantagonisten
DE102010007719A1 (de) 2010-02-10 2011-08-11 Bayer Schering Pharma Aktiengesellschaft, 13353 Progesteronrezeptorantagonisten
US20130029953A1 (en) * 2011-07-28 2013-01-31 Klaus Nickisch Progesterone antagonists

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19706061A1 (de) * 1997-02-07 1998-08-13 Schering Ag Antigestagen wirksame Steroide mit fluorierter 17alpha-Alkylkette
DE19860719A1 (de) * 1998-12-23 2000-06-29 Schering Ag Neue Testosteronderivate und ihre Verwendung zur Langzeittherapie von Androgen-abhängigen Erkrankungen

Also Published As

Publication number Publication date
YU55403A (sh) 2006-03-03
ZA200306122B (en) 2004-11-08
US20020143000A1 (en) 2002-10-03
EA008057B1 (ru) 2007-02-27
UA80529C2 (en) 2007-10-10
PE20020804A1 (es) 2002-10-03
PT1365765E (pt) 2007-10-17
KR20030070096A (ko) 2003-08-27

Similar Documents

Publication Publication Date Title
MY127234A (en) Methods for assessing, improving, or maintaining urogenital health in postmenopausal women
DE69620241T2 (de) Gonadotropin releasing hormon- antagonisten
EA200300750A1 (ru) Применение антигестагенов для ингибирования ускоренного созревания эндометрия в процессе лечения бесплодия
EA200300387A1 (ru) Ингибиторы рецептора ep4 для лечения ревматоидного артрита
EA200300293A1 (ru) Противовоспалительные конденсированные пирролокарбазолы
MX9804850A (es) Antagonistas de hormona liberadora de gonadotropina.
MXPA04004370A (es) Derivados policiclicos de guanina inhibidores de fosfodiesterasa v.
MY135683A (en) Compositions for improving fertility
BR9814923A (pt) Método para tratamento de doença de alzheimer
ATE424209T1 (de) Verwendung von gnrh-agonisten zur unterstützung der lutealphase während einer unfruchtbarkeitsbehandlung
EA200300027A1 (ru) Способ лечения сердечно-сосудистых заболеваний
EA200300266A1 (ru) Новые сложные эфиры апорфина и их применение в терапии
WO2003106450A8 (de) Phenylaminopyrimidine und ihre verwendung als rho-kinase inhibitoren
ATE248832T1 (de) Antagonisten des gonadotropin freisetzenden hormons
EA200500005A1 (ru) Способ лечения повреждения, вызванного реперфузией после ишемии, с использованием антагонистов рецептора аденозина
GB0003025D0 (en) Novel compounds
BR9906926A (pt) Composições e métodos para tratamento de células tendo dna de minuto duplo
UA66850C2 (ru) Способ лечения бесплодия
HK1066243A1 (en) Mullerian inhibiting substance levels and ovarian response
AR032390A1 (es) Uso de gestagenos para inhibir la maduracion acelerada del endometrio durante el tratamiento de la infertilidad
PT1315496E (pt) Tratamento de desordens inflamatorias
EA200001140A1 (ru) СОЕДИНЕНИЯ-ИНГИБИТОРЫ sPLA2 ДЛЯ ЛЕЧЕНИЯ БОЛЕЗНИ
PT1276722E (pt) Inibidores de naftamidina-uroquinase
YU31499A (sh) Proces za dobijanje jedinjenja pirolidinil hidroksamske kiseline
MXPA05007846A (es) Derivados de diazepanes utiles como inhibidores de lfa.

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG MD TJ TM RU